Literature DB >> 1801147

The economic cost of malaria in Africa.

D S Shepard1, M B Ettling, U Brinkmann, R Sauerborn.   

Abstract

Although malaria is the major health problem in Africa, there is little research on its economic impact. This study adapts a framework for assessing the economic costs of illness to available data on malaria. Direct costs of illness are the costs of treatment and control activities, and indirect costs are the value of lost time due to morbidity and premature mortality. Direct costs were estimated by applying the average estimated health systems costs per case to the number of cases. Indirect costs were assessed by multiplying adult output per day times the estimated productive time lost through both adult and childhood cases. As data are not available to assess the economic impact of malaria in Africa as a whole, four case studies were performed on countries or regions for which needed data could be found. The four sites (Rwanda, Solenzo medical district of Burkina Faso, Mayo-Kebbi district, Chad, and Brazzaville, Congo) were chosen to illustrate the diversity in kinds of data which can be used (aggregate national health statistics versus household surveys) and in locations (urban versus rural). Costs were calculated for the recent past and were projected to 1995 based on recent epidemiological trends. Estimates for all sub-Saharan Africa were derived from the averages of these sites. In 1987, a case of malaria cost $9.84 (in 1987 US dollars)--$1.83 in direct costs and $ 8.01 in indirect costs. As the average value of goods and services produced per day in Africa was $0.82, this cost is equivalent to 12 days of output.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1991        PMID: 1801147

Source DB:  PubMed          Journal:  Trop Med Parasitol        ISSN: 0177-2392


  17 in total

Review 1.  Economic aspects of the use of impregnated mosquito nets for malaria control.

Authors:  U Brinkmann; A Brinkmann
Journal:  Bull World Health Organ       Date:  1995       Impact factor: 9.408

2.  Costs analysis of the treatment of imported malaria.

Authors:  Viera Svihrova; Maria Szilagyiova; Elena Novakova; Jan Svihra; Henrieta Hudeckova
Journal:  Malar J       Date:  2012-01-02       Impact factor: 2.979

Review 3.  Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications.

Authors:  S Krishna; N J White
Journal:  Clin Pharmacokinet       Date:  1996-04       Impact factor: 6.447

4.  Malaria Eradication and Educational Attainment: Evidence from Paraguay and Sri Lanka.

Authors:  Adrienne M Lucas
Journal:  Am Econ J Appl Econ       Date:  2010-04

5.  Global health funding and economic development.

Authors:  Greg Martin; Alexandra Grant; Mark D'Agostino
Journal:  Global Health       Date:  2012-04-10       Impact factor: 4.185

6.  Inequities in incidence, morbidity and expenditures on prevention and treatment of malaria in southeast Nigeria.

Authors:  Nkolika P Uguru; Obinna E Onwujekwe; Benjamin S Uzochukwu; Godwin C Igiliegbe; Soludo B Eze
Journal:  BMC Int Health Hum Rights       Date:  2009-09-05

7.  Psychological distress in Ghana: associations with employment and lost productivity.

Authors:  Maureen E Canavan; Heather L Sipsma; Achyuta Adhvaryu; Angela Ofori-Atta; Helen Jack; Christopher Udry; Isaac Osei-Akoto; Elizabeth H Bradley
Journal:  Int J Ment Health Syst       Date:  2013-03-07

Review 8.  Implementation of an insecticide-treated net subsidy scheme under a public-private partnership for malaria control in Tanzania--challenges in implementation.

Authors:  Ritha J A Njau; Don de Savigny; Lucy Gilson; Eleuther Mwageni; Franklin W Mosha
Journal:  Malar J       Date:  2009-08-21       Impact factor: 2.979

Review 9.  Malaria eradication: the economic, financial and institutional challenge.

Authors:  Anne Mills; Yoel Lubell; Kara Hanson
Journal:  Malar J       Date:  2008-12-11       Impact factor: 2.979

10.  Quantifying the economic burden of malaria in Nigeria using the willingness to pay approach.

Authors:  Ayodele Jimoh; Oluyemi Sofola; Amos Petu; Tuoyo Okorosobo
Journal:  Cost Eff Resour Alloc       Date:  2007-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.